Transformation ofin vitrotools for kinase profiling: keeping an eye over the off-target liabilities
Author:
Publisher
Informa Healthcare
Subject
Drug Discovery
Link
http://www.tandfonline.com/doi/pdf/10.1517/17460441.2011.575776
Reference60 articles.
1. The Hit-to-Lead Process at Schering AG: Strategic Aspects
2. Strategies and tactics for optimizing the Hit-to-Lead process and beyond—A computational chemistry perspective
3. Specificity and mechanism of action of some commonly used protein kinase inhibitors
4. Quantitative methods for the analysis of protein phosphorylation in drug development
5. Current In Vitro Kinase Assay Technologies: The Quest for a Universal Format
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Virtual screening in drug discovery: a precious tool for a still-demanding challenge;Protein Homeostasis Diseases;2020
2. Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound–Kinase Activities: A Way toward Selective Promiscuity by Design?;Journal of Chemical Information and Modeling;2016-08-11
3. The preclinical development of regorafenib for the treatment of colorectal cancer;Expert Opinion on Drug Discovery;2014-06-04
4. Modeling of Compound Profiling Experiments Using Support Vector Machines;Chemical Biology & Drug Design;2014-03-13
5. Assessing the Target Differentiation Potential of Imidazole-Based Protein Kinase Inhibitors;Journal of Medicinal Chemistry;2012-12-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3